Department of Molecular Functional Genomics, Geisinger Clinic, Danville, PA 17821, USA.
Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Cells. 2020 Apr 22;9(4):1046. doi: 10.3390/cells9041046.
Heat shock factor 1 (HSF1) is the primary component for initiation of the powerful heat shock response (HSR) in eukaryotes. The HSR is an evolutionarily conserved mechanism for responding to proteotoxic stress and involves the rapid expression of heat shock protein (HSP) molecular chaperones that promote cell viability by facilitating proteostasis. HSF1 activity is amplified in many tumor contexts in a manner that resembles a chronic state of stress, characterized by high levels of gene expression as well as HSF1-mediated non- gene regulation. HSF1 and its gene targets are essential for tumorigenesis across several experimental tumor models, and facilitate metastatic and resistant properties within cancer cells. Recent studies have suggested the significant potential of HSF1 as a therapeutic target and have motivated research efforts to understand the mechanisms of HSF1 regulation and develop methods for pharmacological intervention. We review what is currently known regarding the contribution of HSF1 activity to cancer pathology, its regulation and expression across human cancers, and strategies to target HSF1 for cancer therapy.
热休克因子 1(HSF1)是真核生物中启动强大热休克反应(HSR)的主要成分。HSR 是一种应对蛋白毒性应激的进化保守机制,涉及热休克蛋白(HSP)分子伴侣的快速表达,这些伴侣通过促进蛋白质稳定性来促进细胞活力。在许多肿瘤环境中,HSF1 的活性被放大,类似于一种慢性应激状态,其特征是高水平的基因表达以及 HSF1 介导的非基因调节。HSF1 及其基因靶标对于几种实验性肿瘤模型的肿瘤发生至关重要,并促进癌细胞的转移和耐药性。最近的研究表明,HSF1 作为治疗靶点具有重要的潜力,并促使人们努力了解 HSF1 调节的机制,并开发药理学干预的方法。我们回顾了目前关于 HSF1 活性对癌症病理学的贡献、其在人类癌症中的调节和表达,以及针对 HSF1 进行癌症治疗的策略。